Uses of boraginaceae cynoglossum plant and its extract in preparing medicament for treating diseases such as hyperosteogeny, arthritis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of bone hyperplasia and glaucoma, applied in the field of medicine
Inactive Publication Date: 2009-04-08
赵明生
View PDF0 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0010] There is no information on the application of pharmaceutical compositions that use Boraginaceae Glaucoma plants or their extracts alone as raw materials, or contain Boraginaceae Glaucoma plants or their extracts, for the treatment of hyperosteogeny, intervertebral disc herniation, rheumatism, rheumatoid Related reports on osteoarthritis, osteoarthritis, frozen shoulder, lumbar muscle strain, ankylosing spondylitis and other diseases
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0075] The preparation of embodiment 1 tablet of the present invention
[0076] Take 500 grams of Boraginaceae Glacis, add 10-20 times the amount of medicine, soak in water for 1 hour, put it in a decoction pot for 1 hour, filter out the medicine liquid, add 10 times the amount of water to decoct for 1 hour, and filter out the medicine liquid , combine the two liquid medicines, dehydrate and concentrate to a thick paste, add 20% soluble starch dextrin (or add the same amount of 200 mesh herb powder), mix well, dry at 60°C, pulverize, add 1% magnesium stearate and mix Evenly, pass through a 20-mesh sieve for granulation, and press into tablets, with a tablet weight of 0.5 grams. Dosage: 3-4 tablets each time, three times a day.
Embodiment 2
[0077] The preparation of embodiment 2 tea preparations of the present invention
[0078] Take 1 kg of Boraginaceae Glacis and 80 grams of licorice, crush them together, pass through a 60-80 mesh sieve, and pack 5 grams per bag with filter paper on a tea bag machine to make tea in bags. How to take: Three bags a day, put three bags of medicine in a thermos cup in the morning, brew with boiling water for 30 minutes and drink, then take it continuously throughout the day. This tea bag is sweet and delicious, and can be drunk all year round, or can be added with tea leaves or buckwheat according to the dose of 1 / 10.
Embodiment 3
[0079] The preparation of embodiment 3 decoction of the present invention
[0080] Take 15-20 grams of Boraginaceae Glacis, 1-2 grams of licorice, add 20-30 times of water, soak for 1 hour, put it in a decoction tank, fry for one hour, pour out the liquid medicine, and then add 20 times of water, Decoct for 30 minutes, combine the two decoctions, and take it three times in the morning, middle and evening.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention provides novel application of a borage omphalodes mill plant, which particular relates to application of the borage omphalodes mill plant and an extract of the borage omphalodes mill plant on preparing drugs of treating hyperosteogeny, diskal hernia, arthritis and the like. The drug prepared by the borage omphalodes mill plant and the extract of the borage omphalodes mill plant is used to treat diseases such as cervical vertebral hyperosteogeny, lumbar hyperosteogeny, cervical disc herniation, lumbar disc herniation, rheumatoid arthritis, osteoarthritis, periarthritis humeroscapularis, lumbar muscle strain, ankylosing spondylitis and the like; the drug quickly takes effect, has true and stable efficacy and can relieve and eliminate symptoms of diseases such as hyperosteogeny and arthritis and the like; and by the use of more than one hundred patients, the effective rate is more than 90 percent, so that the invention provides a new choice of clinically treating the diseases such as the cervical vertebral hyperosteogeny, the lumbar hyperosteogeny, the cervical disc herniation, the lumbar disc herniation, the rheumatoid arthritis, the osteoarthritis, the periarthritis humeroscapularis, the lumbar muscle strain, the ankylosing spondylitis and the like.
Description
technical field [0001] The present invention relates to the field of medicine. Background technique [0002] Cervical bone hyperplasia, lumbar bone hyperplasia, cervical disc herniation, lumbar disc herniation, rheumatism, rheumatoid arthritis, osteoarthritis, frozen shoulder, lumbar muscle strain, ankylosing spondylitis and other diseases are all sports It is a common and frequently occurring disease of the system. The main symptoms are acidity, numbness, swelling, pain, and limitation of movement in the affected area. In severe cases, bone tissue deformation, muscle atrophy, and heart, kidney and other organs may be involved. The above-mentioned diseases seriously endanger people's health, cause great suffering to patients, and even make people partially or completely lose their labor force. At present, the above-mentioned diseases are classified as intractable diseases at home and abroad, and the treatment is difficult, and various treatment methods are not satisfactory....
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more